Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Compiled by Giuseppe Curigliano, Division of Medical Oncology, European Institute of Oncology, Milan, Italy
Read the ecancer blog to discover more about these recent news stories, compiled by an expert at the IEO.
Expression of androgen receptors in primary breast cancer
Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non�Small Cell Lung Cancer
Plasma KRAS mutation status is associated with a poor tumour response to EGFR-TKIs in NSCLC.
Phase I oncology studies: Evidence that in the era of targeted therapies patients on lower doses do not fare worse
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.